by Instem Team | Jan 14, 2025 | Resources
Let’s re-imagine the carcinogenicity assessment In the fast-paced and cost-conscious ‘drug to market’ race, momentum can be gained by implementing a Weight of Evidence (WoE) to negate unnecessary preclinical testing. We will present results from a...
by Instem Team | Jan 8, 2025 | Climb, Study Management
Highlights at a Glance Technical fixes and UI improvements for smoother workflows New Charts Modal for visualizing study data by cohort Bulk Task Deletion in the Tasks table Enhanced API Endpoints for better reporting and filtering Improved Filters & Multiselect...
by Instem Team | Dec 16, 2024 | Resources, SEND
Gain insight into the growing prominence of Weight of Evidence approaches in safety assessments and learn specifically how SEND datasets can facilitate the incorporation of relevant preclinical data into specific factors.
by Instem Team | Sep 5, 2024 | Study Management
As the complexity of toxicology studies continues to grow, the systems supporting them must evolve as well. That’s why we are announcing the End-of-Life (EOL) for the Dispense module within the Provantis suite, and outlining what this means for your team. Effective...
by Instem Team | Jun 13, 2024 | Company News, Press Releases
PHILADELPHIA, PA – (BUSINESS WIRE) – June 13, 2024 – Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it will be showcasing its enhanced Provantis® Pathology solution at this year’s Society...
